These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9497506

  • 1. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA, Spósito AC, Mansur AP, Solimene MC, Chamone D, da Luz PL, Pileggi F.
    Arq Bras Cardiol; 1997 Apr; 68(4):257-60. PubMed ID: 9497506
    [Abstract] [Full Text] [Related]

  • 2. [Comparative study of gemfibrozil versus pravastatin in the treatment of patients with coronary artery disease and low HDL cholesterol levels].
    Santos RD, Mansur AP, Safi Júnior J, Giraldez RR, Maranhão RC, Pileggi F, Ramires JA.
    Arq Bras Cardiol; 1995 Aug; 65(2):181-3. PubMed ID: 8554498
    [Abstract] [Full Text] [Related]

  • 3. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
    McKenney JM, Barnett MD, Wright JT, Proctor JP.
    Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
    [Abstract] [Full Text] [Related]

  • 4. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 5. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 May 25; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 6. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
    Bertolami MC, Martinez TL, Faludi AA, Pinto LE, Melo RS, Bismarck ZF, Batlouni M.
    Arq Bras Cardiol; 1991 May 25; 56(5):407-12. PubMed ID: 1823741
    [Abstract] [Full Text] [Related]

  • 7. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun 25; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

  • 8. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M, López de Ocáriz A, Alvarez MP, Ariño M, Azanza JR, Honorato J.
    Rev Med Univ Navarra; 1992 Jun 25; 37(3):127-33. PubMed ID: 1480917
    [Abstract] [Full Text] [Related]

  • 9. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct 25; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 10. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F, Sampietro T, Basta G, Giannasi G, Bionda A.
    Minerva Med; 1995 Oct 25; 86(7-8):299-303. PubMed ID: 7478073
    [Abstract] [Full Text] [Related]

  • 11. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD.
    Am J Cardiol; 2005 Nov 01; 96(9):1266-72. PubMed ID: 16253595
    [Abstract] [Full Text] [Related]

  • 12. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Nov 01; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF.
    Arterioscler Thromb Vasc Biol; 2008 Jun 01; 28(6):1172-8. PubMed ID: 18356553
    [Abstract] [Full Text] [Related]

  • 14. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H, Rhyne J, Abby S, Lai YL, Jones M.
    Curr Med Res Opin; 2006 Nov 01; 22(11):2191-200. PubMed ID: 17076980
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.
    Curr Med Res Opin; 2004 Jan 01; 20(1):13-8. PubMed ID: 14741066
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS, Vitaliano E, Rossi FG, Serra T, Santini G, Bernardi G.
    Clin Ter; 1991 Jan 15; 136(1):31-8. PubMed ID: 1826871
    [Abstract] [Full Text] [Related]

  • 17. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR, Tandon M, Sharma PL.
    Int J Clin Pract; 2007 Nov 15; 61(11):1812-8. PubMed ID: 17935545
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL, Grundy SM.
    Arch Intern Med; 1994 Jan 10; 154(1):73-82. PubMed ID: 8267492
    [Abstract] [Full Text] [Related]

  • 19. Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia.
    Ramires JA, Mansur AP, Solimene MC, Maranhão R, Chamone D, da Luz P, Pileggi F.
    Int J Cardiol; 1995 Feb 10; 48(2):115-20. PubMed ID: 7774989
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999 Feb 10; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.